Solon Moreira

Solon Moreira is a Tenured Associate Professor of Entrepreneurship and Strategy at Temple University’s Fox School of Business and Management. He specializes in Corporate Entrepreneurship, Innovation, and Technology Strategy, teaching PhD, MBA, and Executive programs. His research examines how established corporations collaborate with startups and leverage external knowledge for technological adaptation, focusing on R&D strategies like technology licensing, alliances, and M&As. He has held prior roles at IESE Business School and taught globally in countries including Brazil, Spain, and the U.S.

Education: Ph.D. in Technological Innovation, Entrepreneurship, and Strategy from Copenhagen Business School; MPhil in Innovation, Strategy, and Organization from the University of Cambridge.

Research Interests: Entrepreneurship, Start-up Collaboration, Technology Deals, R&D Strategy, Emerging Technologies, Strategic Intellectual Property. His work has been published in journals like Strategic Management Journal, Organization Science, and Harvard Business Review.

Recent articles focus on themes such as restrictive immigration policies’ impact on multinational innovation, technology licensing dynamics, and gender pay gaps in executive compensation. These studies highlight trends in global innovation ecosystems, corporate R&D strategies, and the evolving role of security analysts.

Awards: Recognized as one of Poets & Quants’ Best 40-Under-40 Professors, and recipient of the International Business Review Best Paper Award and multiple Best Paper Proceedings at the Academy of Management Conference.

Grants & Advising: Secured grants including AI Research Grants from CustomGPT.ai, CEDWC’s Gender Diversity in Technology Deals award, and CIBER funding for biopharmaceutical competitiveness studies. Advised PhD/DBA committees, with students placed at institutions like Santa Clara University and INSPER in Brazil.

Professional Background: Former entrepreneur (co-founder of a Brazilian trading company), with collaborations at Royal Dutch Shell and Novo Nordisk. Engaged in global academic and industry partnerships to advance innovation practices.